Our apologies...
An error has occurred while submitting. Please try again later...
Thank you!
Your form was submitted successfully
Convenient. Curated. Connected. Training for the use of 3M™ Prevena™ Therapy in general surgery.
In a retrospective observational study with high-risk patients undergoing laparotomy, Prevena Therapy aided in:
-
Reduction in Wound Complications*
30-day post-operatively 2.9% (2/69) Prevena Therapy vs.
20.5% (23/112) SOC (p<0.0009)* -
Reduction in dSSIs*†
30-day post-operatively 1.4% (1/69) Prevena Therapy vs.
20.5% (23/112) SOC (p<0.0002)*†
-
Calculations are derived based on relative patient group incidence rate reported in this study.
*Statistically significant (p<0.05).
†NOTE: The use of Prevena Therapy for the reduction in the incidence of deep SSI has not been reviewed by the U.S. FDA
Zaidi A, El-Masry S. Closed incision negative pressure therapy in high-risk general surgery patients following laparotomy: a Prevena™ study.
Colorectal Disease 2016; 19(3):283-287
Proactive Risk Management (PRM) with Prevena Therapy
Resources to help you implement PRM with Prevena Therapy in your practice to help advance the standard of care.
-
View an illustrative guide to aid in risk stratification for general surgery.
-
A guide to supporting the use of Prevena Therapy in a variety of specialties.
Resource Library
Find clinical compendiums, case studies, eGuides, testimonials and more to enrich patient experiences in our resource library.
-
-
3M™ Prevena Restor™ Arthro·Form™ Incision Management System application video (8:08)
See full indications for use and limitations at HCBGRegulatory.3m.com
-
Negative Pressure Wound Therapy for Surgical-site Infections: A Randomized TrialClosed-incision negative-pressure therapy in high-risk general surgery patients following laparotomy: a retrospective studyProphylactic closed incision negative pressure wound therapy is associated with decreased surgical site infection in high-risk colorectal surgery laparotomy woundsClosed incision negative pressure wound therapy is associated with reduced surgical site infection after emergency laparotomy: A propensity matched-cohort analysisConnect with a 3M representativeCONTACT A REP
Learn more about the use of Prevena Therapy in general surgery or request a product demonstration.
NOTE: Specific indications, limitations, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. Rx only.
3M™ Prevena™ 125 and 3M™ Prevena™ Plus 125 Therapy Units manage the environment of closed surgical incisions and remove fluid away from the surgical incision via the application of -125mmHg continuous negative pressure. When used with legally marketed compatible dressings, Prevena 125 and Prevena Plus 125 Therapy Units are intended to aid in reducing the incidence of seroma and, in patients at risk for post-operative infections, aid in reducing the incidence of superficial surgical site infection in Class I and II wounds.
The effectiveness of Prevena Therapy in reducing the incidence of SSIs and seroma in all surgical procedures and populations has not been demonstrated. See full indications for use and limitations at hcbgregulatory.3m.com.
The 3M™ Prevena Restor™ Incision Management System is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudate via the application of negative pressure wound therapy.
